Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Alexza Pharmaceuticals
Alexza Pharmaceuticals
(ALXA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Adasuve
Loxapine
2012-12-21
2024-2026
Schizophrenia
,
Psychotic disorders
,
Bipolar disorder
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Loxapine
cardiotoxicity
,
asthma
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
cigarette smoking
,
migraine disorders
,
headache
,
schizophrenia
,
psychomotor agitation
,
bipolar disorder
,
healthy volunteers/patients
Tozadenant
parkinson disease
Sodium chloride
healthy volunteers/patients
Arm1
parkinson disease
Trinessa
cardiotoxicity
,
healthy volunteers/patients
Arm2
parkinson disease
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use